Results 11 to 20 of about 1,510 (191)

Olopatadine Suppresses the Migration of THP-1 Monocytes Induced by S100A12 Protein [PDF]

open access: yesMediators of Inflammation, 2006
Olopatadine hydrochloride (olopatadine) is an antiallergic drug with histamine H1 receptor antagonistic activity. Recently, olopatadine has been shown to bind to S100A12 which is a member of the S100 family of calcium-binding proteins, and exerts ...
Kazuya Kishimoto   +4 more
doaj   +3 more sources

Efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis using a conjunctival allergen-challenge model

open access: yesClinical Ophthalmology, 2015
Gail Torkildsen,1 Abhijit Narvekar,2 Mark Bergmann3 1Andover Eye Associates, Andover, MA, 2Alcon Research Ltd, Fort Worth, TX, 3Apex Eye, Cincinnati, OH, USA Background: Symptom relief for the duration of 24 hours after treatment would benefit patients ...
Torkildsen G, Narvekar A, Bergmann M
doaj   +1 more source

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

open access: yesClinical Ophthalmology, 2008
Eiichi UchioDepartment of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanAbstract: Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator ...
Eiichi Uchio
doaj   +1 more source

Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment [PDF]

open access: yesClinical Ophthalmology, 2017
Takanori Mizoguchi,1 Mineo Ozaki,2 Nobuchika Ogino3 1Mizoguchi Eye Clinic, Ophthalmology, Sasebo, Japan; 2Ozaki Eye Hospital, Ophthalmology, Miyazaki, Japan; 3Nishigaki Eye Clinic, Ophthalmology, Nagoya, Japan Purpose: To evaluate the efficacy and ...
Mizoguchi T, Ozaki M, Ogino N
doaj   +2 more sources

Pharmacokinetics and safety of olopatadine hydrochloride 0.77% in healthy subjects with asymptomatic eyes: data from 2 independent clinical studies

open access: yesClinical Ophthalmology, 2017
Edward Meier,1 Abhijit Narvekar,2 Ganesh R Iyer,2 Harvey B DuBiner,3 Apinya Vutikullird,4 David Wirta,5 Kenneth Sall61Apex Eye, Mason, OH, 2Alcon Research Ltd., Fort Worth, TX, 3Clayton Eye Center, Morrow, GA, 4WCCT Global, Cypress, 5Eye Research ...
Meier E   +6 more
doaj   +1 more source

Topical olopatadine hydrochloride versus ketotifen fumarate for allergic conjunctivitis

open access: yesJournal of Ophthalmic & Vision Research, 2018
Purpose: Allergic conjunctivitis (AC) is associated with itching, redness, tearing, pain, and burning sensation in the eyes. The inflammatory process is caused by the mechanism of immediate hypersensitivity due to direct contact with the allergen.
Dharmistha Patel   +2 more
doaj   +2 more sources

Pooled analysis of two studies evaluating efficacy and safety of olopatadine hydrochloride 0.77% in patients with allergic conjunctivitis

open access: yesClinical Ophthalmology, 2017
Eugene McLaurin,1 Mark Bergmann,2 Abhijit Narvekar,3 Adeniyi Adewale,3 Paul Gomes,4 Gail Torkildsen5 1Department of Ophthalmology, Total Eye Care, PA, Memphis, TN, 2Department of Ophthalmology, Apex Eye, Cincinnati, OH, 3Department of Ophthalmology ...
McLaurin E   +5 more
doaj   +1 more source

Comparison of efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria: A randomized, double-blind, comparative, parallel group trial

open access: yesIndian Journal of Dermatology, 2016
Objective: To compare efficacy, safety and cost-effectiveness of rupatadine and olopatadine in patients of chronic spontaneous urticaria. Materials and Methods: A 6-week, single-centered, randomized, double blind, parallel group comparative clinical ...
Ganesh N Dakhale   +5 more
doaj   +2 more sources

Maintenance of remission with low-dose olopatadine hydrochloride for itch in well-controlled chronic urticaria

open access: yesClinical, Cosmetic and Investigational Dermatology, 2012
Teruhiko Makino,1 Yoshiaki Takegami,1 Mati Ur Rehman,1 Yoko Yoshihisa,1 Waka Ishida,2 Takashi Toyomoto,3 Tadamichi Shimizu11Department of Dermatology, University of Toyama, Toyama, Japan; 2Department of Dermatology, Niigata Central Hospital, Joetsu ...
Makino T   +6 more
doaj   +1 more source

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

open access: yesClinical Ophthalmology, 2009
Arthur B Epstein1, Peter T Van Hoven2, Alan Kaufman3, Warner W Carr41North Shore Contact Lens and Vision Consultants, Roslyn Heights, NY, USA; 2Primary Eyecare Group PC, Brentwood, TN, USA; 3Adult Allergy Clinic and the Division of Allergy and Immunology,
Arthur B Epstein   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy